🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the efficacy of aprepitant in pre...
Status
Completed
Location
Washington University School of Medicine
Start Date
2005-10
Trial ID
NCT00314743
Treatments Being Tested
This study will evaluate the safety, tolerability, and efficacy of engineer...
Status
Recruiting
Location
City of Hope
Start Date
2019-04-08
Trial ID
NCT03802695
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
MBCCOP - University of South Alabama
Start Date
1994-06
Trial ID
NCT00002571
It is the hypothesis of this protocol that a subset of NSCLC patients with ...
Status
Terminated
Location
Leo W. Jenkins Cancer Center
Start Date
2013-06
Trial ID
NCT02054819
The purpose of the study is to find out if pembrolizumab is a useful treatm...
Status
Recruiting
Location
Memorial Sloan Kettering at Basking Ridge (All Protocol Activities)
Start Date
2025-12-04
Trial ID
NCT07089992
Treatments Being Tested
Patients with CD30 positive DLBCL, primary refractory or in first relapse a...
Status
Recruiting
Location
NL-Rotterdam-ERASMUSMC
Start Date
2018-03-05
Trial ID
NCT03356054
Treatments Being Tested
The purpose of this study is to determine the safe and tolerable, biologica...
Status
Terminated
Location
City of Hope
Start Date
2012-03
Trial ID
NCT01530256
The purpose of this study is to identify a dose of P276-00 that can be safe...
Status
Completed
Location
Government Medical College
Start Date
2009-08
Trial ID
NCT00899054
Treatments Being Tested
Adjuvant Durvalumab vs Placebo for 1 year after complete resection of esoph...
Status
Unknown
Location
Samsung Medical Center
Start Date
2016-02
Trial ID
NCT02520453
Treatments Being Tested
This is a single arm, open-label, multi-center study designed to demonstrat...
Status
Completed
Location
Beijing Cancer Hospital
Start Date
2015-09-10
Trial ID
NCT03349333
Treatments Being Tested